Biomarkers for early detection are the key to fighting Parkinson’s and Alzheimer’s
Leading researchers from all over the world are meeting at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases at the Austria Center Vienna to discuss degenerative diseases, their causes, diagnostic processes and therapeutic approaches.Over the next five to ten years, researchers aim to use biomarkers to detect and treat degenerative brain diseases several years before typical symptoms even arise. · Around 130,000 people in Austria suffer from dementia and 20,000 have Parkinson’s · The number of cases of Alzheimer’s is increasing worldwide, and could reach 110